BIM
BTX.WS

BlackRock Investment Management’s BioTime Inc Warrants (Expiring October 1, 2018) BTX.WS Stock Holding History

BlackRock Investment Management’s Portfolio BTX.WS Stock Details BTX.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-24
Closed – – 4183
2016
Q1 		$0 Buy
+24
New +$16 ﹤0.01% 4132

Other funds holding BTX.WS

ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 39.77% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D Trenton, New Jersey $29.3B AUM 38.15% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock Investment Management's BTX.WS Position: Q2 2016 in Review

BlackRock Investment Management sold out of BioTime Inc Warrants (Expiring October 1, 2018) (BTX.WS) in Q2 2016, closing a stake of 24 shares.

BlackRock Investment Management first reported a position in BTX.WS in Q1 2016 and held it in 1 quarter. The position peaked at $0 in Q1 2016. 38 funds tracked by Wall St. Rank hold BTX.WS as of Q2 2016.

  • BlackRock Investment Management reported no remaining BioTime Inc Warrants (Expiring October 1, 2018) position as of Q2 2016 after selling out during the quarter.
  • BlackRock Investment Management sold 24 BioTime Inc Warrants (Expiring October 1, 2018) shares in Q2 2016.
  • BlackRock Investment Management first reported a position in BioTime Inc Warrants (Expiring October 1, 2018) in Q1 2016 and held it in 1 quarter.
  • BlackRock Investment Management's BioTime Inc Warrants (Expiring October 1, 2018) position peaked at $0 in Q1 2016.
  • 38 funds tracked by Wall St. Rank held BioTime Inc Warrants (Expiring October 1, 2018) as of Q2 2016.

Based on BlackRock Investment Management's 13F filing for Q2 2016, filed 10 Aug 2016.